Ecovative Opens Groundbreaking Patent for Plastic Free Products in Europe
Ecovative announced today that it is opening access to a major European patent to all individuals and businesses who wish to use its MycoComposite™ mycelium materials in their own innovations and businesses in Europe. The company’s renewable material offers a nontoxic, planet-friendly alternative to plastics and other fossil fuel-derived materials.
Ecovative’s MycoComposite invention enables the manufacturing of products that are free of forever chemicals and other toxic substances like formaldehyde. This patent outlines a strategic blueprint for the creation of eco-friendly and renewable mushroom mycelium composites, offering a promising solution to curtail CO2 emissions across diverse industries and combat the escalating climate crisis.
"The goal of Ecovative has always been to provide the 'picks and shovels' for a new generation of businesses realizing the potential of mycelium technology," says Ecovative co-founder and CEO Eben Bayer. "The growing demand for environmentally beneficial products and processes is creating immense new opportunities not to reinvent the wheel, but to change what the wheel is made of, and we're excited to see the new discoveries and scalable solutions made with this versatile technology, for the benefit of Spaceship Earth."
The European Open Patent Program for MycoComposite is intended to encourage innovation in plastic-free products. The patent is already in use around the world in protective packaging, construction materials, architecture and innovative applications to replace petrochemical use. Several successful businesses have already been launched using MycoComposite, notably Loop Biotech which makes a popular line of mycelium coffins and urns.
"Loop Biotech has seen firsthand the huge demand for innovative, planet-friendly solutions enabled by mycelium materials," said Bob Hendrikx, founder of Loop Biotech, which uses MycoComposite material to produce sustainable coffins and urns. "I started this company to help humanity leave a positive footprint on the Earth, which is only possible when we collaborate with living organisms like fungi."
A sharp rise of interest in Europe for entrepreneurial applications of MycoComposite make it an ideal environment to test the potential of open access patents to spur an increase in innovations and businesses around mycelium technology. MycoComposite licensing and partnership opportunities will continue to be available outside of Europe supported by Ecovative’s state-of-the-art spawn and substrate facilities. The company owns numerous patents and patent applications related to mycelium manufacturing and product development globally.
Learn more about the program to open the MycoComposite European patent and what it means for the future of mycelium technology.
About Ecovative:
Ecovative is a biological science and design company, advancing mycelium technology to transform industries with high quality, Earth-friendly materials. Founded in 2007, Ecovative makes mycelium materials and products commercially competitive and accessible to everyone. Leveraging its Mycelium Foundry, dedicated production capacity and a range of industry leading partners, Ecovative grows better materials for everyday needs. To learn more, visit ecovative.com.
About MycoComposite:
MycoComposite is a combination of only two ingredients, mushroom mycelium and shredded plant fibers, such as kenaf, hemp stalks, and other plant-based waste from agriculture. The mycelium binds the material together into a natural composite that is highly versatile and earth-friendly in a range of applications. The process requires little energy and the final product is 100% bio-based returning nutrients to the Earth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230926346447/en/
Contact information
Media:
Lacey Davidson — Lacey@ecovative.com
Media Kit
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom